Please select the option that best describes you:
How do you treat localized well-differentiated neuroendocrine tumor of the breast with Ki-67% 20-30 after surgery?
Is there a distinction between these tumors and patients with breast cancer with neuroendocrine features?
Answer from: Medical Oncologist at Academic Institution
Primary neuroendocrine cancer of the breast is a rare entity and in 2013, WHO classified the neuroendocrine cancers of the breast (NECB) into three subtypes - well-differentiated NE tumors, poorly differentiated small cell carcinoma of the breast, invasive breast cancer with NE differentiation. By d...
Sign in or Register to read more